Laxmi Dental's audit record is clean on its face: unqualified opinions on both standalone and consolidated statements for FY25 and FY26, and a resolved tax dispute with no liability. But the record carries recurring governance and cash-flow concerns: related-party loans without repayment schedules, a deteriorating audit-trail record, a pattern of regulatory lapses, and operating cash flow that has been weak against reported profit.
Key findings
- Related-party loans lack repayment schedules, and a prior receivable breached FEMA rules
Major- In FY2025-26, the auditor reported under CARO clause 3(iii) that repayment schedules were not stipulated for loans/advances in nature of loan, and the auditor was unable to comment on regularity of repayment. On 29 April 2025, Laxmi Dental subscribed to a ₹40.91 crore rights issue from its loss-making subsidiary Bizdent Devices. A ₹15.13 crore related-party receivable as at 31 March 2024, including ₹6.5 crore outstanding over 9 months, resulted in FEMA non-compliances; the company later collected ₹11.92 crore with no penalties levied. - Audit opinions stayed clean, but the audit-trail record deteriorated
Major- The statutory auditor issued unqualified opinions for FY2024-25 and FY2025-26. For FY2024-25, the auditor reported the accounting software "did not have audit trail (edit log) facility". For FY2025-26, the audit-trail feature was operated, but "audit trail of prior year has not been preserved by the Company as per statutory record-retention requirements". The principal auditor relied solely on other auditors' reports for five subsidiaries in both years. - A pattern of regulatory compliance lapses across SEBI, secretarial, FEMA, GST, and income tax
Major- The FY2025-26 corporate governance certificate notes delays in SEBI filings, a delayed disclosure of a Company Secretary resignation, and related-party transactions ratified after the fact on 26 March 2026. The secretarial audit flagged circular resolutions for loan approvals that should have been considered at a Board meeting. The company also received a ₹10.31 lakh GST demand plus interest, and an income-tax show cause notice for AY 2019-20. - Operating cash flow is weak against profit, and IPO proceeds are being redirected
Major- Cumulative CFO of ₹81 crore covered only 0.62x of cumulative operating profit of ₹130 crore over eight years through FY26. FY26 CFO was negative ₹5.00 crore against PAT of ₹26.43 crore. IPO net proceeds of ₹546.63 crore were unutilised as at 31 March 2026, of which ₹54.66 crore was temporarily invested in fixed deposits, and the Board approved a variation to redeploy them toward land acquisition, requiring 90% member approval. - Reported profit is shaped by exceptional items, a tax election, and non-GAAP metrics
Major- Exceptional items of at least 5% of profit before tax occurred in 4 of 8 years. The company exercised the Section 115BAA concessional tax option, producing an average effective tax rate of -18.3% versus the statutory 25.2%. Management presents an "adjusted EBITDA" that adds back ESOP expenses and profit shares of two entities. - Promoter-directors took identical ₹93 lakh packages; institutional shareholders opposed ESOP ratification
Major- Mr. Rajesh Vrajlal Khakhar and Mr. Sameer Kamlesh Merchant each received ₹93 lakhs for FY2025-26, up from ₹84 lakhs. Public institutional shareholders voted 83.47% against ratifying the ESOP 2024 scheme in a postal ballot concluded 20 May 2025. The 21st AGM on 29 September 2025 then approved removing the per-employee ceiling of 50,000 options. - The "debt-free" framing coexists with finance costs and prior secured borrowings
Major- Management described the company as "debt-free" while reporting finance cost of ₹0.3 crores for Q1 FY27. The capital management note states total debt includes liability components of Convertible Preference Shares and current borrowings from the ultimate holding company. A term loan from Aditya Birla Finance of ₹11.37 crore was fully repaid during FY2026. Prior-year borrowings stood at ₹306.44 crore as of 31 March 2023 and ₹379.98 crore as of 31 March 2024. - A layered US holding chain was restructured twice, and a 60%-owned LLP is off the books
Minor- The US holding structure changed during FY2024-25, with Laxmi Dental's direct stake moving to 71.43%. Kids-e-Dental LLP, a 60%-owned jointly controlled entity, reported a 19.8% revenue decline to ₹21.06 crore in FY26, yet its revenue is excluded from consolidated revenue under Ind AS. On 26 March 2026, the Board approved an amalgamation of Bizdent Devices into Laxmi Dental. - Revenue is concentrated in the dental laboratory segment
Clean- In FY2024-25, the Dental Laboratory Products segment contributed 62% of total revenue, with domestic sales exceeding 36% and international sales exceeding 25% of operating revenue. The Aligner Solutions segment contributed 32%.
What to watch
- IPO proceeds variation vote. The AGM vote on redeploying unutilised IPO proceeds requires 90% of votes cast, per the FY2025-26 Annual Report notice.
- Bizdent amalgamation. Completion of the amalgamation announced 26 March 2026, and any disclosures on the ₹40.91 crore rights subscription.
- Palghar land acquisition. Completion of the acquisition and capital deployment, following the letter of intent disclosed in the Q1 FY27 transcript (Jun 2026).
- Income-tax show cause notice. Resolution of the notice for AY 2019-20, received 28 February 2025.
- GST audit clarification. Outcome of the CGST/IGST notice for April 2021 to March 2022, received 29 August 2025.
Bottom line: This is a disclosed and audited record with a clean tax outcome and a straightforward revenue profile. The risk sits in the gap between reported profit and the cash and governance behind it: related-party flows without repayment schedules, a weak CFO-to-EBITDA conversion, and a pattern of procedural lapses. Watch the AGM vote on IPO proceeds and the amalgamation outcome, and read the profit line with the exceptional items and non-GAAP adjustments in mind.